Beth Bilski
Family Medicine · Newark, DENPI 1750328076
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 102 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AstraZeneca at 34.8% of the total. Reporting peaked in 2019 at $818 and has fallen 69.1% since, to $253 in 2025.
Across 102 payments — averaging $28.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Johnson & Johnson$426
- Boehringer Ingelheim$322
- Abbott$209
- Pfizer$129
- Lilly USA, LLC$129
- plus $706 from 14 others
What the payments were for
- Food & beverage$2,941100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 36 | $1,026 |
| Johnson & Johnson | 4 | $426 |
| Boehringer Ingelheim | 9 | $322 |
| Abbott | 8 | $209 |
| Pfizer | 9 | $129 |
| Lilly USA, LLC | 10 | $129 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $107 |
| AbbVie(2 entities) | 3 | $101 |
| Idorsia Pharmaceuticals US Inc | 2 | $92 |
| Axsome Therapeutics, Inc. | 1 | $86 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $83 |
| GSK | 3 | $59 |
| Amgen | 2 | $47 |
| Biohaven Pharmaceuticals, Inc. | 2 | $30 |
| Genentech USA, Inc. | 1 | $24 |
| Exact Sciences | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Astellas Pharma US Inc | 1 | $16 |
| Shire North American Group Inc | 1 | $13 |
| Merck | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,947 in reported general payments places this provider in the 80th percentile of 352 family medicine providers in Delaware.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 16 | $15,603 |
| Omeprazole | 60 | $1,018 |
| Losartan Potassium | 54 | $838 |
| Bupropion XlBupropion Hcl | 27 | $797 |
| Amlodipine Besylate-BenazeprilAmlodipine Besylate/Benazepril | 18 | $725 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 25 | $684 |
| Celecoxib | 19 | $595 |
| Atorvastatin Calcium | 48 | $558 |
| Montelukast Sodium | 22 | $512 |
| Amlodipine Besylate | 58 | $461 |
| Metoprolol Succinate | 28 | $453 |
| Levothyroxine Sodium | 55 | $448 |
| Duloxetine Hcl | 14 | $412 |
| Lisinopril | 63 | $370 |
| Pantoprazole Sodium | 12 | $268 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $129 | $15,60316 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 352 family medicine providers in Delaware.
Other family medicine in Newark
- Michelle PapaNewark$23K
- Ian MyersNewark$17K
- Robert WinterNewark$12K
- Judy LimNewark$12K
- Huy leNewark$10K
- Arlen StoneNewark$10K
- Imelyn LaheyNewark$8K
- Angela Davis BrownNewark$8K
- Robert CallahanNewark$7K
- George NameyNewark$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.